O'Rahilly S, Choi W H, Patel P, Turner R C, Flier J S, Moller D E
Department of Medicine, Beth Israel Hospital, Boston, Massachusetts 02215.
Diabetes. 1991 Jun;40(6):777-82. doi: 10.2337/diab.40.6.777.
We used the recently described technique of single-stranded conformation-polymorphism (SSCP) analysis to examine the insulin-receptor locus. First, the ability of the method to detect known mutations and polymorphisms in the insulin-receptor coding sequence was assessed. Regions of the insulin-receptor sequence containing 16 different nucleotide changes, 9 in patient genomic DNA and 7 as cloned cDNA in plasmids, were analyzed. All 9 patient genomic DNA mutants and 5 of 7 plasmid mutants exhibited variant SSCP patterns. To investigate the potential of the technique for screening many patients, the 5 exons that encode the tyrosine kinase domain of the insulin receptor were examined in 30 unrelated white subjects with non-insulin-dependent diabetes mellitus (NIDDM). Exons 17-21 were amplified from genomic DNA with polymerase chain reaction and subjected to SSCP analysis. Exons 19, 20, and 21 revealed no bands of aberrant migration, suggesting a high degree of conservation of these sequences. One diabetic subject had an SSCP variant in exon 18. Direct sequencing of this subject's genomic DNA revealed a heterozygous missense mutation (Lys1068----Glu1068). Five different SSCP patterns were detected in exon 17. Based on direct sequencing, these patterns were explained by combinations of three different nucleotide substitutions, two of which were common silent polymorphisms. One subject had a heterozygous missense mutation Val985---- Met985. Allele-specific oligonucleotide hybridization confirmed the presence of these mutations in the appropriate diabetic subjects and also detected the Val985 mutation in heterozygous form in 1 of 13 nondiabetic white subjects. SSCP analysis is a sensitive rapid method for screening for mutations in the insulin-receptor gene.(ABSTRACT TRUNCATED AT 250 WORDS)
我们采用最近描述的单链构象多态性(SSCP)分析技术来检测胰岛素受体基因座。首先,评估了该方法检测胰岛素受体编码序列中已知突变和多态性的能力。分析了胰岛素受体序列中包含16种不同核苷酸变化的区域,其中9种在患者基因组DNA中,7种以质粒形式克隆的cDNA存在。所有9个患者基因组DNA突变体和7个质粒突变体中的5个表现出可变的SSCP模式。为了研究该技术筛查众多患者的潜力,在30名非胰岛素依赖型糖尿病(NIDDM)的无关白人受试者中检测了编码胰岛素受体酪氨酸激酶结构域的5个外显子。用聚合酶链反应从基因组DNA中扩增外显子17 - 21,并进行SSCP分析。外显子19、20和21未显示异常迁移条带,表明这些序列具有高度保守性。一名糖尿病受试者在外显子18中有一个SSCP变异体。对该受试者的基因组DNA进行直接测序,发现一个杂合错义突变(Lys1068→Glu1068)。在外显子17中检测到5种不同的SSCP模式。基于直接测序,这些模式由三种不同核苷酸替代的组合解释,其中两种是常见的沉默多态性。一名受试者有一个杂合错义突变Val985→Met985。等位基因特异性寡核苷酸杂交证实了这些突变在合适的糖尿病受试者中的存在,并且在13名非糖尿病白人受试者中的1名中也检测到了杂合形式的Val985突变。SSCP分析是一种筛查胰岛素受体基因突变的灵敏、快速方法。(摘要截短于250字)